|  | | | | | | | | | What you need to know about the coronavirus today | | | | | | Infections surge in India
India’s death toll from the coronavirus pandemic surpassed 20,000 and case numbers surged as the south Asian country pushed ahead with relaxations to its almost two-month lockdown amid grim economic forecasts.
The rate of both new virus infections and deaths are rising at the fastest pace in three months, as officials lift a vast lockdown of India’s 1.3 billion people that has left tens of thousands without work and shuttered businesses.
The country reported 467 new deaths on Tuesday, taking the toll to 20,160. It also recorded 22,252 new infections, increasing the total to 719,665. India on Monday overtook Russia as the third most affected country globally, behind the United States and Brazil.
Health officials fear the number of deaths, which usually lag behind the detection of new infections, could rise significantly in coming weeks.
Chaos on the borders
Hundreds of police officers and soldiers are being deployed to enforce the closure of the busy and highly porous border between Australia’s two most populous states, New South Wales and Victoria, as officials grapple to contain a new coronavirus outbreak.
Daily travel permits will be granted to people who live in border towns and cities but with the closure just hours away at 11.59 p.m. on Tuesday, the application system was still being developed.
Over in New Zealand, the national airline will not take new bookings for three weeks as the country looks to limit the number of citizens returning home to reduce the burden on overflowing quarantine facilities.
“The last thing we need are hastily set up facilities to meet demand,” Housing Minister Megan Woods said in a statement.
Care home deaths blame game
British Prime Minister Boris Johnson faced a growing storm on Tuesday after saying some care homes didn’t follow procedures to stem the spread of COVID-19 deaths, sparking an accusation that he was trying to rewrite history.
Britain has one of the highest death tolls in the world from COVID-19, at more than 44,000, with around 20,000 dying in care homes, according to government statistics.
While the government has been heavily criticized by opposition politicians and some medics over the slow delivery of protective clothing and testing in care homes, Johnson appeared to suggest blame for the outbreaks lay with the care homes themselves.
“We discovered too many care homes didn’t really follow the procedures in the way that they could have, but we’re learning lessons,” Johnson said on Monday.
A Reuters Special Report detailed how the government’s focus on preventing emergency wards from being overwhelmed left care home residents and staff exposed to COVID-19.
A stronger-than-usual will to live
After a record 112 days on a specialized life-support system, a South Korean COVID-19 patient is recovering from double lung transplant surgery, doctors say, in only the ninth such procedure worldwide since the coronavirus outbreak began.
The 50-year-old woman was diagnosed with the disease and hospitalized in late February and then spent 16 weeks on extracorporeal membrane oxygenation support, which involves circulating a patient’s blood through a machine that adds oxygen to red blood cells. That’s the longest that any COVID-19 patient in the world has spent on ECMO support, her doctors said.
Lee Sun-hee, a head nurse of the ECMO program who has cared for the patient since February, said the woman seemed to have a stronger-than-usual will to live, in part driven by being a mother of two. Lee said the woman already knows the first thing she wants to do when released from the hospital: “To get a nice bath.”
| | | | | | | | | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources. Here’s a look at our coverage.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | | | | | | | | | | | Life under lockdown | | Samita Chavan used to wake up at 3am every day to the sound of her neighbour’s wet grinder in Mumbai’s Dharavi slum. Now, she is adjusting to a rare silence after three months of lockdown that saw tens of thousands of migrant workers leave the city. Dharavi, believed to be Asia’s largest slum, has been hailed as a success story in the battle against the coronavirus pandemic, bringing cases from a daily average of 100 in April to about 10 in July, say city officials, thanks to a strict lockdown.
| | | | Emel Evcin first heard on a phone call with a friend that nearby COVID-19 cases had rendered her Melbourne apartment block quarantined, yet on checking through the curtains, she saw not medical staff but law enforcement. “I looked outside from my window and no nurses, no cleaners, no food - just lots of cops,” the 42-year-old mother of two told Reuters by phone from her two-bedroom flat. “This is not a lockdown, this is a lockup.” | | | | | COVID Science | | | | | | Only certain patients likely to benefit from antibody-rich plasma Doctors may need to be more selective about who to treat with blood plasma from recovered COVID-19 patients, with a preference toward those whose symptoms have just begun, new research suggests. Researchers have been testing whether infusions of antibody-rich convalescent plasma can help COVID-19 patients recover faster. On Friday, investigators in The Netherlands said they stopped their convalescent plasma trial prematurely after only 86 hospitalized patients had been enrolled because nearly 80% were found to already have their own neutralizing antibodies. | | | | | | | | | | | | | Top Stories on Reuters TV | | | | | | | |
